Cargando…
Valproate monotherapy induced-delirium due to hyperammonemia: A report of three adult cases with different types of presentation
One of the important adverse effects of valproate is delirium due to hyperammonemia. In this case report series, we are reporting three cases with interesting and different types of clinical presentation on valproate monotherapy. Valproate-induced delirium may be mistaken for psychosis or worsening...
Autor principal: | Pradeep, R. Johnson |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738345/ https://www.ncbi.nlm.nih.gov/pubmed/19742224 http://dx.doi.org/10.4103/0019-5545.42400 |
Ejemplares similares
-
The Menacing Side of Valproate: A Case Series of Valproate-induced Hyperammonemia
por: Elwadhi, Deeksha, et al.
Publicado: (2017) -
Use of carglumic acid in valproate‐induced hyperammonemia: 25 pediatric cases
por: Palomino Pérez, Laura María, et al.
Publicado: (2020) -
Valproate-induced hyperammonemia - uncovering an underlying inherited metabolic disorder: a case report
por: Mehta, Shaine, et al.
Publicado: (2018) -
Hyperammonemia Due to Empyema
por: Wada, Hiroshi, et al.
Publicado: (2023) -
Levocarnitine for valproate-induced hyperammonemia in the psychiatric setting: A case series and literature review
por: Brown, Lauren M., et al.
Publicado: (2018)